SYRACUSE, N.Y., March 14, 2022 /PRNewswire/ — PDO Max® Director of Training and Clinical Development, Dina BenDavid, DNP, MS, FNP-C, has been selected as a finalist for the Aesthetic and Anti-Aging Medicine World Congress (AMWC) prize category for Best Threads Treatment. The AMWC is the world’s leading aesthetic conference in the world. Over 12,000 delegates from 120 countries will be in attendance.
This prestigious award gives recognition to physicians and companies aspiring for innovation and the advancement of Aesthetics and Anti-Aging medicine. Only the best-of-the-best get nominated, and the scientific panel selected BenDavid as a finalist for her patent-pending Cheek Pop™ procedure with PDO Max® threads. She exclusively uses PDO Max threads for this procedure. BenDavid’s signature treatment first lifts the fat pads of the cheek to a higher position, then, as the threads safely dissolve, the skin continues to produce collagen for true rejuvenation.
From now until March 14th (12:59 am – PST), licensed medical professionals have the chance to view and rate (1-5 stars) physician and industry finalist cases. In order to vote for the AMWC Award winners, please login using your Euromedicom/AMWC account details. You may register for an account if you do not have one.
Click here to vote for Dina, select Best Aesthetic Clinical Case Application. Scroll down and select Cheek Pop™ with PDO Max Threads.
About: PDO MAX, Inc. is headquartered in Liverpool, NY, and is a female-owned medical device provider for medical aesthetic needs in the U.S. PDO Max is the trusted provider of hundreds of medical practices utilizing its proprietary FDA cleared (K190245) Polydioxanone (PDO) threads- in-cannula. PDO Max offers hands-on individual instructional courses, which cover the application of PDO thread techniques. For more information regarding PDO MAX threads, to place an order, or to schedule a training, please contact PDO MAX at 800-670-0225 or visit https://www.pdomax.com.
Media Contact:
Diana Daly
1.800.670.0225
SOURCE PDO Max, Inc.
